US Patent Issued to JACOBIO PHARMACEUTICALS on April 22 for "Binding molecule specific for LIF and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,168, issued on April 22, was assigned to JACOBIO PHARMACEUTICALS Co. LTD. (Beijing).

"Binding molecule specific for LIF and use thereof" was invented by Qinghao Liu (Beijing), Jun Tao (Beijing), Wenlai Zhou (Beijing), Shanshan He (Beijing), Haiyan Yang (Beijing), Hongling Wang (Beijing) and Guiqun Yang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a binding molecule specific for LIF and use thereof. Specifically, provided is an isolated antibody or an antigen-binding fragment thereof that binds to LIF and inhibits the activity of LIF. Also provided are uses of the isolated antibody or the antigen-binding fragment thereof in trea...